COMPANY

Cadenza Bio

Keywords: small molecule inflammatory diseases

Location: Yukon, OK · source · Aug 28, 2025

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Seed · $2.44M · announced Dec 14, 2023 Company release ↗
Source quote
- Dec 14, 2023 · Company release ↗
  “(Cadenza), a privately-held biotechnology company focused on developing novel small molecule compounds for demyelinating and inflammatory diseases, has announced the initial closing of an oversubscribed $2.44M Series Seed financing”

Raises announced in these releases: $2.44M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Feb 7, 2025 Partnership Partnership / licensing announced Feb 7, 2025. Source: company's own press page. source ↗
Dec 14, 2023 Raise Seed · $2.44M source ↗

Last 2 years.

Feb 7, 2025 Partnership / licensing announced Feb 7, 2025. Source: company's own press page. source ↗